Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3011325	s-hivab	— (—)	220	231	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications: immunosuppressive drugs

107

6.35

42.84

1.1

—

L04AX Other immunosuppressants

102

5.40

28.23

1.0

1.1

—

Second line medication for Crohn's disease

106

5.29

28.11

1.0

1.1

—

L04AA Selective immunosuppressants

7.97

22.98

1.1

1.0

—

Autoimmune diseases related-to ILD

142

3.68

18.64

1.0

1.1

—

ILD medications

124

3.11

14.64

1.0

1.1

—

First line medication for Crohn's disease

118

3.16

14.61

1.0

1.1

—

Fever of other and unknown origin

3.79

13.01

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

123

2.96

12.59

1.1

—

5-aminosalicylic acid

5.62

12.40

1.0

1.1

—

Inflammatory bowel disease treatment related agents

138

2.80

12.19

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

121

2.89

11.85

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

119

2.90

11.77

1.1

1.0

—

Contact with and exposure to communicable diseases

4.04

11.73

1.0

1.1

—

Oral corticosteroids

132

2.83

11.61

1.0

1.1

—

Other and unspecified anaemias

4.45

11.47

1.0

1.1

—

Other anaemias

4.44

11.43

1.0

1.1

—

Autoimmune diseases

121

2.73

10.73

1.1

1.0

—

IBD patients in KELA-register

4.71

10.69

1.0

1.1

—

Other diseases of blood and blood-forming organs, wide

5.56

10.68

1.1

1.0

—

Liquid cancers, helper endpoint

4.54

10.61

1.0

1.1

—

Noninfective enteritis and colitis

3.58

10.57

1.0

1.1

—

Aplastic and other anaemias

4.04

10.46

1.0

—

Dialysis, with operation codes

12.04

10.32

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

8.16

10.28

1.0

—

Care involving dialysis

18.83

10.25

1.0

—

Renal failure

4.19

10.06

1.0

—

Nephropathy related operations

11.29

10.04

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

14.58

9.98

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

143

2.70

9.97

1.0

1.1

—

L04AD Calcineurin inhibitors

12.18

9.83

1.1

—

Inflammatory bowel disease, strict (require KELA)

4.29

9.56

1.0

1.1

—

Persons with potential health hazards related to communicable diseases

3.38

9.41

1.0

1.1

—

Biological medication for rheuma

4.89

9.30

1.1

1.0

—

Any gastric operation

3.00

8.89

1.1

—

GASTRO-related operations

3.00

8.89

1.1

—

Tumor necrosis factor alpha inhibitors

4.88

8.82

1.1

—

Used for control exclusion in common control thyroid runs

113

2.59

8.76

1.1

1.0

—

Other diseases of pleura

3.85

8.35

1.1

1.0

—

Inflammatory bowel disease

3.74

8.32

1.0

1.1

—

Diseases of liver

3.81

8.22

1.0

—

Chronic kidney disease

6.33

8.02

1.0

1.1

—

Sleep apnoea

116

2.62

7.87

1.1

1.0

—

Extracorporeal dialysis

18.41

7.60

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

100

2.95

7.46

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

4.40

7.42

1.0

—

Other diseases of the respiratory system

8.34

7.30

1.1

1.0

—

Other respiratory disorders and diseases

8.34

7.30

1.1

1.0

—

Disorders of other endocrine glands

3.17

7.28

1.1

1.0

—

Secondary hypertension

15.56

7.17

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

4.48

7.17

1.0

1.1

—

Ulcerative colitis

3.93

7.14

1.0

1.1

—

Sleep apnoea, including avohilmo

120

2.48

7.14

1.1

1.0

—

Presence of other functional implants

3.47

7.05

1.0

—

Ulcerative colitis (strict definition, require KELA)

4.37

6.95

1.0

1.1

—

Transplanted organ and tissue status

9.31

6.78

1.0

1.1

—

Purpura and other haemorrhagic conditions

7.16

6.69

1.0

—

Other diseases of liver

5.87

6.59

1.1

1.0

—

Drug-induced neutropenia

12.26

6.58

1.1

1.0

—

Non-follicular lymphoma

12.25

6.57

1.1

1.0

—

Reimbursement for rheumatic diseases

105

2.85

6.55

1.1

—

Rheumatoid arthritis, including avohilmo

3.44

6.55

1.1

1.0

—

General symptoms and signs

127

2.25

6.52

1.1

1.0

—

Sulfasalazine

3.80

6.52

1.1

—

Pneumonia, organism unspecified

132

2.39

6.45

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

4.05

6.34

1.1

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

18.04

6.26

1.1

1.0

—

Polyarthropathies

108

2.48

6.25

1.0

—

Renal tubulo-interstitial diseases

140

2.34

6.14

1.0

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

5.95

6.13

1.0

—

COPD

3.40

6.10

1.0

—

Rheumatoid arthritis

3.63

5.95

1.1

1.0

—

Other septicaemia

3.44

5.90

1.0

1.1

—

ILD, hospital admission 2, with pulmonary infections

15.02

5.90

1.1

1.0

—

Persons encountering health services in other circumstances

3.02

5.84

1.0

—

Agranulocytosis

8.02

5.83

1.1

1.0

—

Other respiratory diseases principally affecting the interstitium

6.85

5.72

1.1

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

121

2.39

5.71

1.0

—

All chronic kidney diseases

2.73

5.64

1.0

1.1

—

Covid-19 confirmed case

3.18

5.58

1.0

—

Heart failure,strict

3.18

5.57

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

5.01

5.55

1.0

1.1

—

Glomerular disorders in diseases classified elsewhere

10.02

5.52

1.0

—

Implicit viral Sepsis

5.36

5.52

1.1

1.0

—

Heart failure, not strict

2.67

5.52

1.0

—

Viral Sepsis

5.18

5.38

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

151

2.13

5.33

1.0

1.1

—

Thrombocytopenia, unspecified

11.28

5.29

1.0

—

Abnormal spermatozoa

9.11

5.28

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

108

2.30

5.27

1.0

1.1

—

108

2.30

5.27

1.0

1.1

—

Malaise and fatigue

2.83

5.21

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

139

2.15

5.20

1.0

1.1

—

COPD, hospital admission 2, with asthma infections

4.57

5.04

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

149

2.11

4.98

1.0

1.1

—

Other interstitial pulmonary diseases

6.88

4.94

1.1

1.0

—

Interstitial lung disease

6.88

4.94

1.1

1.0

—

Interstitial lung disease endpoints

6.88

4.94

1.1

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

4.33

4.92

1.0

1.1

—

Adalimumab

6.01

4.90

1.1

—

Glomerular diseases

5.42

4.90

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

158

2.04

4.89

1.1

1.0

—

Any reimbursement code in KELA

2.55

4.82

1.1

1.0

—

Bronchitis

160

2.01

4.81

1.0

1.1

—

Influenza and pneumonia

153

2.04

4.81

1.1

1.0

—

All pneumoniae

153

2.05

4.77

1.0

1.1

—

COPD/asthma related infections

108

2.13

4.76

1.0

1.1

—

COPD/asthma/ILD related infections

108

2.13

4.76

1.0

1.1

—

Personal history of other diseases and conditions

5.19

4.74

1.1

—

Sleep disorders (combined)

136

2.01

4.69

1.0

—

COPD (mode)

4.78

4.58

1.0

—

ILD-related respiratory insufficiency

14.07

4.58

1.1

1.0

—

Hypopituitarism

8.20

4.56

1.0

—

136

1.98

4.49

1.0

1.1

—

Mucosal proctocolitis

4.82

4.49

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3.41

4.46

1.1

1.0

—

Other/unspecified seropositive rheumatoid arthritis

3.41

4.46

1.1

1.0

—

Hernia of abdominal wall, postoperative

5.79

4.43

1.0

—

Seropositive rheumatoid arthritis

3.40

4.43

1.1

1.0

—

Acute upper respiratory infections

145

2.00

4.38

1.0

1.1

—

Seropositive rheumatoid arthritis, wide

3.34

4.31

1.1

1.0

—

Other bacterial diseases

133

2.07

4.30

1.0

1.1

—

ILD, hospital admissions

6.26

4.29

1.1

1.0

—

Etanercept

8.91

4.28

1.1

1.0

—

Kidney transplant status

11.70

4.27

1.0

—

Emphysema

11.69

4.27

1.0

—

Asthma, unspecified (mode), excluding more controls

2.65

4.21

1.0

1.1

—

Heart failure, strict

2.66

4.18

1.0

—

Other disorders of kidney and ureter

6.93

4.16

1.0

—

ILD, hospital admissions 1, main diag only

6.93

4.16

1.1

1.0

—

Septicaemia

2.75

4.14

1.0

—

Asthma, unspecified (mode)

2.59

4.04

1.0

1.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

10.02

4.01

1.1

1.0

—

Long labour

3.11

4.00

1.1

—

Dyspnoea

142

2.03

3.98

1.0

1.1

—

Pulmonary heart disease

3.79

3.88

1.1

1.0

—

Pulmonary embolism

3.79

3.88

1.1

1.0

—

Heart failure and bmi 25plus

3.18

3.87

1.1

1.0

—

Diabetic maculopathy, excluding more controls

5.27

3.82

1.0

—

Acute renal failure

5.27

3.82

1.0

—

ILD medications: azathioprine

4.29

3.81

1.0

—

Explicit Sepsis

2.55

3.78

1.0

1.1

—

Volume depletion

8.76

3.77

1.0

—

Amputation

8.76

3.77

1.0

—

Other dialysis

12.05

3.76

1.0

—

Obesity due to excess calories

108

2.32

3.74

1.1

1.0

—

Bacterial infection, other or unspecified

2.43

3.72

1.0

—

All-cause Heart Failure

2.55

3.72

1.0

—

Azathioprine

4.14

3.70

1.0

—

Seronegative rheumatoid arthritis

6.67

3.67

1.0

—

Medical treatment for female infertility

2.98

3.64

1.0

1.1

—

GI-bleeding

3.50

3.59

1.1

1.0

—

Obesity

144

2.08

3.57

1.1

1.0

—

Persons encountering health services in other circumstances, wide

144

1.82

3.57

1.1

1.0

—

Obesity and other hyperalimentation

144

2.07

3.56

1.1

1.0

—

Exposure to unspecified factor

175

1.85

3.56

1.1

1.0

—

Invasive ventilation

7.79

3.56

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

7.79

3.55

1.1

1.0

—

All kidney diseases

162

1.86

3.48

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

2.12

3.46

1.1

—

Other pulmonary diagnosis

2.12

3.46

1.1

—

Other bacterial diseases

141

1.89

3.45

1.0

1.1

—

Other nutritional deficiencies

149

2.02

3.43

1.1

1.0

—

Obesity related asthma

2.66

3.38

1.0

—

Ulcerative colitis, NAS

3.75

3.38

1.0

1.1

—

Mood [affective] disorders

160

1.82

3.34

1.1

1.0

—

Mood disorders

160

1.82

3.33

1.1

1.0

—

Osteopathies and chondropathies

100

2.24

3.30

1.0

1.1

—

Enlarged lymph nodes

4.35

3.30

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.41

3.29

1.0

1.1

—

Bacterial infection, other or unspecified

2.29

3.28

1.0

1.1

—

Ulcerative ileocolitis

8.60

3.26

1.0

—

Melanocytic naevi of other and unspecified parts of face

8.59

3.26

1.2

1.0

—

Diabetic maculopathy

4.29

3.23

1.0

1.2

—

Noninfectious colitis NAS

4.74

3.23

1.0

1.1

—

Other chronic obstructive pulmonary disease

2.64

3.23

1.0

—

Complications of labour and delivery

2.21

3.22

1.0

1.1

—

Heart failure and antihypertensive medication

3.54

3.21

1.1

1.0

—

Anaemias

2.82

3.21

1.0

—

COPD related to multimorbidity

2.82

3.20

1.0

—

Assault by bodily force

5.34

3.19

1.4

1.1

—

Other ulcerative colitis

6.38

3.18

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

6.38

3.18

1.0

—

Crohn's disease of small intestine

6.38

3.18

1.0

1.1

—

Duodenal ulcer

6.37

3.18

1.0

—

Heart failure and coronary heart disease

2.76

3.17

1.1

1.0

—

Maternal care for other known or suspected fetal problems

2.82

3.17

1.0

1.1

—

COPD differential diagnosis

2.06

3.14

1.1

—

ILD differential diagnosis

2.06

3.14

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

2.95

3.08

1.0

—

Abnormal findings on diagnostic imaging of lung

2.40

3.08

1.0

—

Other and unspecified psoriasis

7.51

3.05

1.0

—

Fibrosis and cirrhosis of liver

7.51

3.05

1.0

—

Idiopathic pulmonary fibrosis

7.51

3.05

1.2

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

7.51

3.05

1.0

—

Nonalcoholic fatty liver disease

5.01

3.05

1.1

1.0

—

Other diseases of the digestive system

3.17

3.05

1.1

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.50

3.03

1.0

1.1

—

Depression

159

1.79

3.01

1.1

1.0

—

Dental caries

2.67

3.01

1.1

1.0

—

Asthma, excluding more controls

2.06

3.00

1.0

1.1

—

Later onset COPD, excluding more controls

5.15

2.98

1.0

—

Injuries involving multiple body regions

10.03

2.98

1.0

—

Other specified/unspecified arthritis

2.75

2.98

1.1

1.0

—

Cirrhosis of liver, NAS

10.02

2.98

1.0

—

Decubitus ulcer and pressure area

10.02

2.98

1.0

—

Gastroduodenal ulcer

3.54

2.97

1.0

—

Abnormalities of breathing

140

1.78

2.96

1.0

1.1

—

Zoster [herpes zoster]

2.34

2.94

1.0

1.1

—

Bacterial Sepsis

2.35

2.91

1.0

—

Headache

117

1.98

2.90

1.1

1.0

—

Mood disorders, excluding more controls

141

1.78

2.88

1.1

1.0

—

Ulcerative rectosigmoiditis

5.39

2.87

1.0

—

Other complications of surgical and medical care, not elsewhere classified

5.39

2.87

1.0

—

Heterophoria

5.39

2.87

1.1

1.0

—

Secondary uncertain malignant neoplasm

5.39

2.87

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

6.68

2.86

1.2

1.0

—

Sudden idiopathic hearing loss

6.67

2.86

1.2

1.0

—

Asthma

2.02

2.86

1.0

1.1

—

Nonsuppurative otitis media

2.45

2.84

1.1

—

COPD, hospital admissions

2.44

2.79

1.0

—

Abnormal findings on diagnostic imaging of other body structures

4.45

2.79

1.0

—

Implicit bacterial Sepsis

2.49

2.77

1.0

—

Other (seronegative) rheumatoid arthritis, wide

3.92

2.77

1.0

—

Other or unspecified ileus, impaction or obstruction

3.91

2.77

1.0

—

Early onset COPD, excluding more controls

3.91

2.77

1.0

—

Exclusions for E4_PCOS_BROAD

3.08

2.76

1.0

1.1

—

Single delivery by caesarean section

2.99

2.76

1.0

1.2

—

Acute peritonitis

8.35

2.75

1.0

—

Amputation of toe

8.35

2.75

1.0

—

Unspecified kidney failure

8.34

2.75

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.51

2.74

1.1

1.0

—

Abdominal aortic aneurysm (AAA)

8.27

2.73

1.0

—

Diseases of the respiratory system

2.10

2.73

1.0

1.1

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

5.01

2.73

1.0

1.1

—

Pediculosis, acariasis and other infestations

6.01

2.70

1.0

—

Poisoning by medicine

2.59

2.70

1.3

1.0

—

COPD, early/later onset

2.39

2.69

1.0

—

Hyperkinetic disorders, excluding more controls

2.95

2.62

1.1

1.0

—

Poisoning by drugs, medicaments and biological substances

2.46

2.61

1.3

1.0

—

Other arthritis (FG)

2.46

2.61

1.1

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

4.67

2.59

1.0

—

Intestinal infectious diseases

177

1.71

2.58

1.1

1.0

—

Erysipelas

106

1.94

2.58

1.0

1.1

—

Hidradenitis suppurativa

7.16

2.55

1.0

—

Other demyelinating diseases of the central nervous system

7.16

2.55

1.0

—

Scabies

7.16

2.55

1.0

—

Visual field defects

5.46

2.54

1.0

—

Diseases of peritoneum

5.46

2.54

1.0

—

Pleural effusion

5.46

2.54

1.2

1.0

—

Sequelae of external causes of morbidity and mortality

2.73

2.54

1.2

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.86

2.54

1.1

—

Peripheral artery operations in Hilmo

5.46

2.54

1.0

—

Intestinal infectious diseases

158

1.66

2.53

1.1

1.0

—

Diabetes mellitus in pregnancy

2.25

2.51

1.0

1.1

—

Diabetic retinopathy, strict definition

3.27

2.51

1.0

1.1

—

Abdominal and pelvic pain

127

1.70

2.49

1.1

1.0

—

Supervision of high-risk pregnancy

2.89

2.47

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

127

1.70

2.47

1.1

1.0

—

Gout, unspecified

3.81

2.46

1.0

—

Acute bronchitis

2.25

2.46

1.0

1.1

—

False labour

2.36

2.45

1.1

—

Other disorders of lacrimal gland

2.46

2.44

1.1

—

Psoriasis

2.55

2.44

1.1

1.0

—

Non-small cell lung cancer, including Hilmo

5.14

2.42

1.0

—

Viral infections characterized by skin and mucous membrane lesions

179

1.72

2.41

1.0

1.1

—

Hydronephrosis

5.00

2.40

1.2

1.0

—

Enterocolitis due to Clostridium difficile

5.00

2.40

1.0

—

Hypothyroidism, strict autoimmune

1.91

2.39

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

144

1.66

2.39

1.1

1.0

—

Osteoporosis

3.37

2.39

1.0

—

DVT of lower extremities and pulmonary embolism

2.28

2.38

1.1

1.0

—

L04AC Interleukin inhibitors

6.26

2.37

1.2

1.0

—

Collagenous colitis

6.26

2.37

1.0

—

Mouth breathing

2.21

2.36

1.1

1.0

—

Methotrexate

4.12

2.36

1.1

1.0

—

Zoster [herpes zoster]

4.12

2.36

1.0

—

Other noninfective gastroenteritis and colitis

2.61

2.35

1.0

—

Gout, FINNGEN

3.02

2.34

1.0

—

Persistent mood disorders

2.82

2.34

1.0

—

Dermatitis

133

1.87

2.27

1.0

1.1

—

Insulin, fast-acting

2.22

2.26

1.0

1.1

—

Diseases of the digestive system

2.11

2.25

1.1

1.0

—

Caries of dentine

2.54

2.23

1.1

1.0

—

Assault

3.11

2.22

1.3

1.0

—

Sequelae with surgical and medical care as external cause

3.11

2.22

1.2

1.0

—

Other necrotizing vasculopathies

5.56

2.21

1.0

—

Other peripheral vascular diseases

5.56

2.21

1.2

1.0

—

Other infectious diseases

5.56

2.21

1.0

—

Finngen Rheumatological endpoints

146

1.64

2.21

1.0

—

Cellulitis

2.68

2.20

1.1

1.0

—

Diabetic nephropathy, excluding more controls

3.47

2.20

1.0

1.2

—

131

1.82

2.20

1.1

1.0

—

Insulin, fast-acting or short human

2.19

2.20

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

162

1.65

2.19

1.0

1.1

—

Thyroiditis, ILD-related definition

3.34

2.18

1.0

—

Hyperkinetic disorders

2.50

2.17

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

155

1.74

2.16

1.1

1.0

—

129

1.82

2.15

1.1

1.0

—

Other Crohn's disease

4.29

2.15

1.0

1.1

—

Abnormal results of function studies

4.29

2.15

1.2

1.0

—

Spondyloarthritis

3.00

2.14

1.0

—

Atrial fibrillation and flutter with reimbursement

3.18

2.14

1.0

—

Venous thromboembolism

2.02

2.13

1.1

1.0

—

Alcohol use disorder, Swedish definition

119

1.85

2.09

1.1

1.0

—

Other and unspecified dermatitis

102

1.96

2.09

1.0

1.1

—

Budesonide

3.20

2.09

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

2.07

2.09

1.0

—

Neurological diseases

107

1.69

2.09

1.0

1.1

—

Non-ischemic cardiomyopathy

2.78

2.07

1.1

1.0

—

Crohn disease (strict definition, all UC cases excluded)

5.01

2.07

1.0

1.1

—

Disorders of mineral metabolism

5.01

2.07

1.0

—

COPD-related respiratory insufficiency

5.00

2.07

1.0

—

Viral pneumonia

3.50

2.05

1.0

1.1

—

Gout, strict definition

3.50

2.05

1.0

1.1

—

Other cataract

2.23

2.04

1.0

—

Gestational diabetes (for exclusion)

1.99

2.04

1.0

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.25

2.02

1.2

1.0

—

Postpartum care and examination

3.00

2.01

1.0

1.1

—

Other hearing loss

2.84

2.01

1.1

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

3.08

2.01

1.0

—

Car occupant injured in other and unspecified transport accidents

2.50

2.01

1.2

1.1

—

Certain disorders involving the immune mechanism

2.81

2.00

1.0

—

Other gastritis (incl. Duodenitis)

2.81

2.00

1.0

—

Lung cancer and mesothelioma

3.95

1.97

1.0

—

Demyelinating diseases of the central nervous system

3.34

1.96

1.1

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

3.34

1.96

1.0

—

Other CVD (FINNGEN)

4.85

1.94

1.0

—

Herpesviral [herpes simplex] infections

2.35

1.94

1.0

1.1

—

Crohn's disease NAS

4.55

1.94

1.0

—

Other and unspecified drugs and medicaments

4.55

1.94

1.0

1.1

—

Disorders of parathyroid gland

3.29

1.94

1.0

—

Early onset COPD

2.73

1.93

1.0

—

Later onset COPD

3.04

1.92

1.0

—

COPD, hospital admissions 1, only main diagnosis

2.48

1.92

1.0

1.1

—

Hyperparathyroidism

3.71

1.91

1.0

—

Diabetic nephropathy

2.93

1.90

1.0

1.1

—

Suicide or other Intentional self-harm

2.24

1.90

1.1

—

Systemic connective tissue disorders

2.24

1.90

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.05

1.90

1.1

—

Single delivery by forceps and vacuum extractor

2.86

1.89

1.0

1.3

—

Dermatitis and eczema

172

1.55

1.89

1.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.12

1.89

1.1

—

Injuries to the neck

2.31

1.87

1.1

—

Crohn disease

2.86

1.86

1.0

1.1

—

Disturbance of activity and attention

2.40

1.85

1.1

—

Alcohol dependence

2.39

1.85

1.2

1.0

—

MS-disease / Multiple Sclerosis

3.53

1.83

1.2

1.1

—

Infective dermatitis

3.53

1.83

1.0

1.1

—

Herpesviral [herpes simplex] infections

3.53

1.83

1.0

—

Psoriatic and enteropathic arthropathies

3.53

1.83

1.2

1.0

—

Complications of procedures, not elsewhere classified

156

1.64

1.83

1.0

1.1

—

Viral pneumonia (unknown virus, not influenza)

4.17

1.82

1.0

—

Inflammatory diseases of the central nervous system

4.17

1.82

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.95

1.81

1.1

—

Disorders of skin appendages

115

1.82

1.81

1.1

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.91

1.81

1.0

—

Malignant neoplasm

101

1.70

1.81

1.0

1.1

—

Insulin, intermediate and long-acting

112

1.82

1.80

1.0

1.1

—

Psoriasis vulgaris

2.57

1.80

1.1

—

Other and unspecified polyneuropathies, also in other diseases

3.05

1.79

1.0

—

Disorders of lacrimal system

2.05

1.79

1.1

—

Erysipelas

1.89

1.78

1.1

—

Other heart diseases

1.89

1.78

1.1

1.0

—

Infections, IBD-co-morbidities

2.86

1.78

1.0

—

Constipation

131

1.64

1.76

1.1

—

Hypertension, essential

1.70

1.76

1.1

1.0

—

Dermatophytosis

3.34

1.74

1.0

1.1

—

Adjustment and management of implanted device

3.33

1.74

1.0

—

Certain infectious and parasitic diseases

109

1.61

1.73

1.1

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

120

1.75

1.73

1.0

1.1

—

Type 1 diabetes

2.22

1.73

1.0

—

Diabetic retinopathy, excluding more controls

2.47

1.72

1.0

1.2

—

Genitourinary diseases

1.77

1.72

1.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

3.85

1.71

1.0

1.1

—

Crohn disease (strict definition, require KELA)

3.85

1.71

1.0

1.1

—

Hypokalaemia

3.85

1.71

1.0

—

Malignant neoplasm of bronchus and lung

3.32

1.70

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

104

1.75

1.69

1.1

—

Transport accidents

1.81

1.66

1.2

1.0

—

Diabetes, varying definitions

149

1.53

1.66

1.1

1.0

—

Other sleep disorders

3.16

1.66

1.2

1.1

—

Problems related to lifestyle

2.80

1.65

1.3

1.0

—

Diabetes mellitus

149

1.53

1.64

1.1

1.0

—

Other and unspecified tonsillitis

1.91

1.64

1.1

—

Gout

2.45

1.64

1.0

—

Gastrointestinal diseases

1.71

1.63

1.0

1.1

—

Other viral diseases, not elsewhere classified

2.09

1.63

1.1

—

Mental and behavioural disorders due to alcohol

122

1.73

1.62

1.1

1.0

—

Other obstetric conditions, not elsewhere classified

1.86

1.62

1.1

—

Other acute lower respiratory infections

114

1.76

1.62

1.0

1.1

—

Bacterial, viral and other infectious agents

3.57

1.61

1.0

1.1

—

Other embolism and thrombosis

3.57

1.61

1.0

—

Hydrocele

3.57

1.61

1.0

1.1

—

Intestinal stricture

2.38

1.61

1.0

—

Type 2 diabetes, wide definition

104

1.66

1.61

1.0

—

Asthma (mode)

1.72

1.60

1.0

1.1

—

Other diseases of urinary system

135

1.54

1.60

1.0

1.1

—

Benzodiazepine use

178

1.51

1.60

1.1

1.0

—

Endocrine, nutritional and metabolic diseases

105

1.59

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

140

1.50

1.59

1.1

—

Diseases of the skin and subcutaneous tissue

124

1.54

1.59

1.0

—

Spondylopathies (FG)

2.69

1.58

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

121

1.74

1.57

1.1

—

Other maternal disorders predominantly related to pregnancy

1.78

1.57

1.0

1.1

—

Inguinal hernia

0.40

1.55

1.0

—

Opioids

138

1.51

1.55

1.1

1.0

—

Metabolic disorders

129

1.56

1.54

1.0

1.1

—

Codeine

136

1.52

1.54

1.1

1.0

—

Gout, idiopatic and unspecified

2.43

1.53

1.0

1.1

—

Impingement syndrome of shoulder

0.00

1.52

0.0

1.0

—

Other follicular disorders

3.34

1.52

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

3.34

1.52

1.0

1.1

—

Raynaud syndrome

3.34

1.52

1.2

1.1

—

Ankylosing spondylitis, ICD10

3.34

1.52

1.0

1.1

—

Persons encountering health services for specific procedures, not carried out

3.34

1.52

1.4

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.34

1.52

1.0

1.1

—

Open wound of forearm

3.34

1.52

1.0

1.1

—

Hypotension

3.33

1.52

1.0

—

Episodal and paroxysmal disorders

144

1.48

1.52

1.0

—

Speech therapy

0.00

1.52

0.0

1.0

—

Internal derangement of knee

1.91

1.51

1.1

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

2.94

1.51

1.0

1.1

—

Any event in cancer register

125

1.55

1.51

1.0

1.1

—

Labour and delivery complicated by fetal stress [distress]

2.08

1.50

1.1

—

Maternal care for known or suspected fetal abnormality and damage

2.50

1.49

1.0

1.1

—

Cardiodefibrillation

2.15

1.49

1.0

—

Provisional assignment of new diseases of uncertain etiology

123

1.70

1.49

1.0

—

Other viral diseases

100

1.79

1.49

1.1

—

Acute sinusitis

107

1.73

1.48

1.2

1.1

—

Insulin medication

116

1.67

1.48

1.0

—

Emotionally unstable personality disorder

2.43

1.47

1.4

1.0

—

Codeine or tramadol medication

161

1.46

1.47

1.1

1.0

—

Codes for special purposes

124

1.69

1.45

1.0

—

Neurological diseases, wide definition

1.98

1.45

1.1

1.0

—

Allergic contact dermatitis

2.50

1.45

1.0

1.1

—

Implicit Sepsis

110

1.65

1.44

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

112

1.57

1.44

1.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

2.22

1.44

1.0

1.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

2.79

1.44

1.0

1.1

—

Myocardial infarction, with ST-elevation

3.13

1.44

1.0

—

Otitis externa, unspecified

2.73

1.43

1.2

1.0

—

Hypertensive diseases

1.60

1.43

1.1

1.0

—

Hypertension

1.60

1.43

1.1

1.0

—

All influenza

2.31

1.42

1.2

1.0

—

Mental and behavioural disorders due to psychoactive substance use

137

1.62

1.42

1.1

1.0

—

Disorders of gallbladder, biliary tract and pancreas

137

1.52

1.40

1.0

1.1

—

Non-rheumatic valve diseases

1.94

1.40

1.0

1.1

—

Other diseases of intestines

165

1.45

1.40

1.1

1.0

—

Substance use, excluding alcohol

2.18

1.39

1.0

—

2.42

1.39

1.0

—

All influenza (not pneumonia)

2.41

1.39

1.3

1.0

—

Depression or dysthymia

1.61

1.38

1.1

1.0

—

Sub-endpoint used in defining T1D endpoints

2.00

1.37

1.0

1.1

—

Chronic apical periodontitis

166

1.44

1.37

1.1

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

1.94

1.37

1.1

—

Paralytic ileus and intestinal obstruction

2.19

1.36

1.0

—

Atrial fibrillation and flutter

2.24

1.36

1.0

—

Excessive vomiting in pregnancy

2.94

1.36

1.2

—

Bacterial, viral and other infectious agents

2.94

1.36

1.0

1.1

—

Twin gestation

2.94

1.36

1.0

1.2

—

Diseases of the myoneural junction and muscle

2.94

1.36

1.0

—

Ulcer of lower limb, not elsewhere classified

2.94

1.36

1.0

—

Other CVD

2.94

1.36

1.0

—

Recurrent or chronic depression

1.76

1.35

1.0

—

Viral and other specified intestinal infections

1.92

1.34

1.2

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

104

1.72

1.34

1.2

1.0

—

Fibroblastic disorders

0.00

1.34

0.0

1.0

—

Maternal care for other conditions predominantly related to pregnancy

2.13

1.33

1.2

1.1

—

Type 1 diabetes, wide definition, subgroup 1

2.13

1.33

1.0

—

Diseases of external ear

1.91

1.33

1.1

—

Diabetic retinopathy

1.98

1.33

1.0

1.1

—

Asthma-related pneumonia

1.91

1.32

1.0

1.1

—

Asthma-related pneumonia or sepsis

1.91

1.32

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

1.91

1.32

1.0

1.1

—

Hypothyroidism and >3 levothyroxin purchases

1.93

1.32

1.1

1.0

—

Hypothyroidism, levothyroxine purchases

1.93

1.32

1.1

1.0

—

Hypothyroidism (congenital or acquired)

1.93

1.31

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

1.66

1.30

1.0

1.1

—

Hypothyroidism, other/unspecified

146

1.49

1.30

1.1

—

Type 2 diabetes

134

1.48

1.29

1.1

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.77

1.29

1.1

1.0

—

Other diseases of upper respiratory tract

145

1.44

1.28

1.1

1.0

—

Multiple gestation

2.78

1.28

1.0

1.2

—

Cerebral palsy and other paralytic syndromes

2.78

1.28

1.0

—

Valvular heart disease excluding rheumatic fever

1.87

1.28

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.84

1.28

1.1

—

Other degenerative diseases of the nervous system

2.13

1.27

1.1

1.0

—

Visual disturbances

1.72

1.26

1.1

—

Diagnoses used for exclusion with ILD

2.29

1.26

1.1

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

165

1.46

1.26

1.1

1.0

—

Asthma (only as main-diagnosis)

1.63

1.25

1.0

1.1

—

Visual disturbances and blindness

107

1.68

1.25

1.1

—

Graves disease, strict definition

2.40

1.24

1.0

—

Persons encountering health services for specific procedures and health care

164

1.43

1.24

1.1

—

Disorders of thyroid, IBD co-morbidities

2.25

1.24

1.0

—

Sleep disorders

163

1.46

1.23

1.1

1.0

—

Pacemaker

2.19

1.22

1.1

1.0

—

Cystitis

119

1.50

1.22

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

148

1.46

1.22

1.1

—

Seropositive rheumatoid arthritis, strict definition

2.63

1.21

1.0

—

Cardiomyopathy

2.63

1.21

1.0

1.1

—

Undetermined asthma

2.63

1.21

1.0

—

Undetermined asthma, excluding more controls

2.63

1.21

1.0

—

Dental pulpitis, including avohilmo

163

1.43

1.20

1.1

1.0

—

Acute pharyngitis

2.15

1.20

1.0

1.1

—

Chronic lower respiratory diseases

169

1.39

1.19

1.0

1.1

—

Bacterial intestinal infections, IBD co-morbidities

2.31

1.18

1.0

—

Ventral hernia

2.11

1.18

1.0

—

Cutaneous abscess, furuncle and carbuncle

1.93

1.16

1.2

1.1

—

Ankylosing spondylitis

2.50

1.15

1.0

1.1

—

Other bursopathies

2.50

1.15

1.0

1.1

—

Unspecified acute lower respiratory infection

2.50

1.15

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

2.05

1.15

1.1

—

Prolonged pregnancy

0.00

1.14

0.0

1.1

—

Papulosquamous disorders

1.81

1.14

1.1

1.0

—

Obesity, other/unspecified

1.81

1.14

1.1

1.0

—

Acute nasopharyngitis (common cold)

2.48

1.14

1.0

1.1

—

External causes of morbidity and mortality

1.55

1.13

1.1

1.0

—

Other/unspecified dorsalgia

1.76

1.13

1.1

—

Alcohol use disorder, ICD-based

1.68

1.13

1.2

1.0

—

Diseases of middle ear and mastoid

122

1.54

1.13

1.1

—

Other viral diseases, not elsewhere classified

2.00

1.11

1.0

1.1

—

Type 1 diabetes, wide definition

1.96

1.10

1.0

—

Pregnancy examination and test

2.29

1.10

1.0

1.1

—

Scoliosis

2.38

1.09

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

2.38

1.09

1.0

1.1

—

Aortic aneurysm

2.22

1.09

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

111

1.61

1.08

1.1

—

Substance abuse

135

1.53

1.08

1.1

1.0

—

Insulin, fast-acting (human)

2.19

1.08

1.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.19

1.08

1.1

—

Psychiatric diseases

128

1.41

1.07

1.1

1.0

—

Other and unspecified iron deficiency

1.86

1.07

1.0

1.1

—

Strabismus

1.86

1.06

1.1

—

Other anxiety disorders

118

1.54

1.05

1.1

—

Nausea and vomiting

1.92

1.05

1.2

1.0

—

Substance abuse, excluding more controls

123

1.52

1.05

1.1

1.0

—

Other strabismus

1.92

1.05

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

136

1.45

1.04

1.0

1.1

—

Infections of the skin and subcutaneous tissue

144

1.51

1.04

1.1

1.0

—

Fibromyalgia

2.27

1.03

1.0

—

FESS (DNB20)

2.27

1.03

1.0

1.1

—

Ethmoidectomy

2.27

1.03

1.0

1.1

—

Colectomy operation

2.27

1.03

1.0

—

Benign paroxysmal vertigo

1.96

1.03

1.0

—

Injury, poisoning and certain other consequences of external causes

1.59

1.03

1.2

1.0

—

Hypo-osmolality and hyponatraemia

2.26

1.02

1.0

—

Gonarthrosis, primary, with knee surgery

0.47

1.02

1.2

1.0

—

Otitis externa

1.92

1.02

1.1

1.0

—

Other viral diseases

1.73

1.01

1.0

1.1

—

Type 2 diabetes, definitions combined

123

1.43

1.01

1.1

1.0

—

Urticaria and erythema

1.69

1.01

1.1

1.0

—

Nonorganic sleeping disorders, excluding more controls

1.88

1.00

1.1

1.0

—

Fissure and fistula of anal and rectal regions

1.88

1.00

1.1

1.0

—

Ectopic pregnancy

2.00

1.00

1.3

1.0

—

Thyrotoxicosis, other and/or unspecified

2.00

1.00

1.0

—

Other soft tissue disorders, not elsewhere classified

158

1.37

0.99

1.0

1.1

—

Parasetamol

106

1.43

0.99

1.1

1.0

—

Calcific aortic valvular stenosis

2.00

0.99

1.0

—

Calcific aortic valvular stenosis, operated

2.00

0.99

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.00

0.99

1.0

—

Operations 2 for CAVS

2.00

0.99

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

1.99

0.99

1.0

—

Excessive, frequent and irregular menstruation

1.63

0.99

1.1

—

Candidiasis

0.00

0.97

0.0

1.0

—

Other disorders of eye and adnexa

0.00

0.97

0.0

1.0

—

Pre-eclampsia or poor fetal growth

1.70

0.97

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.67

0.97

1.1

—

Antenatal screening

1.94

0.97

1.0

1.1

—

0.00

0.97

0.0

1.1

—

Conduction disorders

1.96

0.96

1.1

—

Peritonsillar abscess

1.80

0.96

1.0

—

Use of hypnotics and sedatives

146

1.38

0.96

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.66

0.96

1.1

—

Nonorganic sleeping disorders

1.77

0.94

1.1

—

Colonic or urogenital fistula

1.77

0.94

1.1

1.0

—

Other antidepressants

148

1.35

0.94

1.1

1.0

—

Hernia of abdominal wall

1.61

0.93

1.0

1.1

—

Artificial joint operation, meniscal resection

137

0.62

0.93

1.0

—

Abnormal findings on antenatal screening of mother

2.22

0.93

1.0

1.1

—

Other symptoms and signs involving the digestive system and abdomen

2.22

0.93

1.2

1.0

—

Other bacterial intestinal infections

2.22

0.93

1.0

—

Shoulder lesions

113

0.59

0.93

1.1

—

Oxycodone

1.78

0.93

1.1

1.0

—

Acute appendicitis, no complications

141

1.48

0.92

1.0

—

Acute alcohol intoxication

1.73

0.92

1.0

—

Procreative management

1.73

0.91

1.2

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

124

1.51

0.91

1.0

1.1

—

Arthropathies

134

1.36

0.91

1.1

1.0

—

Tonsillectomy and adenotomy

115

1.45

0.91

1.1

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

2.14

0.91

1.2

1.1

—

Iron deficiency anaemia

1.66

0.90

1.0

1.1

—

Coxarthrosis, primary

0.49

0.90

1.0

—

Viral and other specified intestinal infections

1.63

0.90

1.2

1.0

—

Disorders of choroid and retina

118

1.45

0.90

1.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

1.93

0.89

1.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.63

0.89

1.0

1.1

—

Injury of eye and orbit

2.07

0.89

1.0

—

Chronic diseases of tonsils and adenoids

126

1.40

0.89

1.1

1.0

—

Pre-eclampsia

1.91

0.88

1.0

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.04

0.88

1.0

—

Other bacterial intestinal infections

1.86

0.87

1.0

—

Benign neoplasms

179

0.71

0.85

1.1

1.0

—

Personality disorders

1.67

0.85

1.3

1.0

—

Pre-eclampsia or eclampsia

1.78

0.84

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

0.59

0.83

1.0

—

Other disorders of ear

127

1.39

0.83

1.1

1.0

—

Depression medications

1.64

0.82

1.3

1.0

—

Accidents

105

1.38

0.82

1.1

1.0

—

Acute alcohol intoxication, ICD10

1.74

0.82

1.0

—

Other disorders of skin and subcutaneous tissue

122

1.46

0.81

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

184

1.35

0.81

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

101

1.39

0.81

1.1

1.0

—

Cholelithiasis

117

1.41

0.81

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

120

1.40

0.81

1.0

1.1

—

Perineal laceration during delivery

1.72

0.81

1.0

1.1

—

Gonarthrosis,primary

110

0.62

0.81

1.0

—

Thyrotoxicosis

1.70

0.80

1.0

1.1

—

Complications of medical and surgical care

150

1.41

0.80

1.0

1.1

—

Diseases of male genital organs

1.51

0.79

1.0

—

Presence of other devices

0.00

0.79

0.0

1.0

—

Rheumatism, unspecified

0.00

0.79

0.0

1.0

—

Follicular cysts of skin and subcutaneous tissue

1.82

0.79

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

1.68

0.79

1.0

—

Disorders of lens

1.52

0.79

1.0

—

Type 2 diabetes, strict (exclude DM1)

125

1.36

0.78

1.1

1.0

—

Other disorders of bone

1.67

0.78

1.1

1.0

—

Disorders of the thyroid gland

156

1.34

0.78

1.1

—

Specific personality disorders

1.67

0.78

1.4

1.0

—

Adenomyosis (Endometriosis of uterus)

0.00

0.78

0.0

1.0

—

Urticaria

1.62

0.78

1.1

—

Other disorders of urethra and urinary system

106

1.43

0.77

1.0

1.1

—

Anxiety (asthma-related co-morbidities)

127

1.40

0.76

1.1

1.0

—

Injuries to the head

180

1.30

0.76

1.1

1.0

—

Congenital malformations of the circulatory system

0.00

0.76

0.0

1.0

—

Cardiovascular diseases

101

1.38

0.76

1.1

1.0

—

Lichen planus, including avohilmo

0.00

0.76

0.0

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.70

0.76

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

125

1.35

0.75

1.1

1.0

—

Acute appendicitis

163

1.38

0.75

1.0

—

Disorders of eyelid, lacrimal system and orbit

145

1.36

0.74

1.0

1.1

—

Retention of urine

1.64

0.73

1.0

—

Haemorrhage in early pregnancy

1.62

0.73

1.0

1.1

—

Ovarian dysfunction

2.00

0.72

1.4

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.00

0.72

1.0

—

Dermatophytosis

150

1.40

0.72

1.1

1.0

—

Insomnia

165

1.32

0.72

1.0

1.1

—

Anxiety disorders, excluding more controls

136

1.34

0.71

1.1

1.0

—

Polycystic ovarian syndrome, broad definition

1.75

0.71

1.3

1.0

—

Tinnitus

1.75

0.71

1.1

—

Hypothyroidism, drug reimbursement

1.96

0.71

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

117

1.45

0.71

1.0

1.1

—

Female infertility, associated with anovulation

1.92

0.70

1.0

1.1

—

Other condition

1.92

0.70

1.0

1.1

—

Poor fetal growth

1.71

0.70

1.0

1.1

—

Preterm labour and delivery

1.71

0.69

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

0.58

0.69

1.0

—

Bleeding

119

1.37

0.69

1.0

1.1

—

Asthma, including avohilmo

177

1.27

0.69

1.0

1.1

—

Carpal tunnel syndrome

111

1.43

0.69

1.0

1.1

—

Necrosis of pulp, including avohilmo

143

1.39

0.69

1.1

1.0

—

Chronic sinusitis

1.53

0.68

1.0

—

Other superficial mycoses

1.85

0.68

1.0

—

Open wound of lower leg

1.85

0.68

1.0

1.1

—

Use of pramipexole

1.85

0.68

1.2

1.0

—

severe traumatic brain injury, does not include concussion

1.85

0.68

1.0

—

Deforming dorsopathies

1.64

0.68

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

1.53

0.68

1.2

1.1

—

Neurotic, stress-related and somatoform disorders

160

1.31

0.68

1.1

1.0

—

Pediculosis, acariasis and other infestations

1.67

0.68

1.0

1.1

—

Personality disorders, excluding more controls

1.56

0.68

1.3

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

102

0.60

0.68

1.0

—

Nutritional anaemias

1.50

0.68

1.0

1.1

—

Injuries to the wrist and hand

183

1.29

0.68

1.1

1.0

—

Other external causes of accidental injury

105

1.34

0.67

1.1

1.0

—

Other systemic involvement of connective tissue (FG)

1.65

0.67

1.1

1.0

—

Post-traumatic stress disorder

1.79

0.66

1.0

—

Thyrotoxicosis with diffuse goitre

1.79

0.66

1.0

—

Disorders of vitreous body

1.55

0.66

1.0

—

Bacterial pneumonia (organism specified)

1.51

0.65

1.1

—

Artrosis, including avohilmo

124

0.71

0.64

1.1

1.0

—

Unspecified fall

102

1.45

0.63

1.2

1.0

—

Other medical care

1.50

0.63

1.0

1.1

—

Caries of dentine, including avohilmo

1.35

0.62

1.1

1.0

—

Anxiety disorders

162

1.29

0.62

1.1

1.0

—

1.63

0.62

1.0

—

Care involving use of rehabilitation procedures

119

1.39

0.61

1.0

1.1

—

Hyperlipidaemia, other/unspecified

1.59

0.61

1.1

1.0

—

Injuries to the elbow and forearm

152

1.33

0.60

1.0

1.1

—

Exposure to other specified factors

175

1.31

0.60

1.2

1.0

—

Other shoulder lesions

0.00

0.60

0.0

1.1

—

Deep endometriosis

0.00

0.60

0.0

1.0

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.60

0.0

1.0

—

Bell's palsy

0.00

0.60

0.0

1.0

—

Palmar fascial fibromatosis [Dupuytren]

0.00

0.60

0.0

1.0

—

Meniscus derangement

0.60

0.59

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

139

1.27

0.59

1.1

1.0

—

Glaucoma suspect

1.54

0.59

1.0

—

Congenital malformations of heart and great arteries

0.00

0.59

0.0

1.0

—

In situ neoplasms

1.56

0.58

1.1

1.0

—

Diseases of the ear and mastoid process

153

1.25

0.58

1.1

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.58

0.0

1.0

—

Superficial injury of lower leg

1.51

0.58

1.3

1.0

—

Chondropathies

1.71

0.57

1.2

1.1

—

Mycoses

1.48

0.57

1.0

—

All anxiety disorders

138

1.32

0.57

1.1

1.0

—

Unspecified haematuria

1.48

0.56

1.0

—

Disorders of psychological development

1.64

0.56

1.3

1.1

—

Appendicitis, broad definition

167

1.30

0.55

1.0

—

Anterior Iridocyclitis

1.62

0.55

1.0

1.1

—

Disturbances of skin sensation

1.54

0.55

1.0

1.1

—

Melanocytic naevi

1.54

0.55

1.1

—

Percutaneous Coronary Intervention

1.35

0.55

1.1

1.0

—

Other joint disorders

134

1.26

0.54

1.1

1.0

—

Diseases of appendix

167

1.30

0.54

1.0

—

Scabies

1.58

0.54

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.50

0.54

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

168

0.71

0.54

1.1

1.0

—

Low back pain

152

1.28

0.53

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.48

0.53

1.1

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.48

0.53

1.1

1.0

—

Acute tubulo-interstitial nephritis

115

1.35

0.53

1.0

1.1

—

Disorders of vitreous body and globe

1.46

0.53

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

137

1.28

0.53

1.1

—

Other and unspecified disorders of vitreous body

1.45

0.53

1.0

—

Other and unspecified urticaria

1.54

0.53

1.0

1.1

—

Other and unspecified effects of external causes

1.52

0.52

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.36

0.52

1.1

1.0

—

Haemorrhoids and perianal venous thrombosis

1.51

0.52

1.0

1.1

—

Benign neoplasm: Colon

0.61

0.52

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.50

0.51

1.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.50

0.51

1.0

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.47

0.51

1.0

1.1

—

Leiomyoma of uterus

0.63

0.50

1.1

1.0

—

Migraine with aura

1.38

0.50

1.2

1.1

—

Other intervertebral disc disorders

136

0.75

0.49

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

141

1.31

0.49

1.2

1.0

—

Peripheral artery disease

1.50

0.49

1.0

—

Iridocyclitis

1.56

0.48

1.0

—

Other systemic involvement of connective tissue

1.56

0.48

1.1

1.0

—

Emergency coronary revascularization (for ACS)

1.30

0.48

1.0

—

Actinic keratosis

1.51

0.48

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

158

0.72

0.47

1.1

—

Coxarthrosis

0.61

0.47

1.0

—

Cerebrovascular diseases (FINNGEN)

1.46

0.47

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

106

1.29

0.46

1.0

—

Solid cancers, helper endpoint

101

1.29

0.46

1.0

1.1

—

Stroke, including SAH

0.66

0.46

1.1

1.0

—

Premature rupture of membranes

1.43

0.46

1.1

—

Pain in limb

151

1.24

0.46

1.0

1.1

—

Intracranial injury

130

1.31

0.46

1.1

1.0

—

Panic disorder

1.43

0.46

1.1

1.0

—

Superficial injury of wrist and hand

1.43

0.46

1.1

—

Diseases of oesophagus, stomach and duodenum

162

1.22

0.45

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.37

0.45

1.0

1.1

—

Other retinal disorders

100

1.32

0.45

1.0

—

Disorders of adult personality and behaviour

1.43

0.45

1.4

1.0

—

Excessive earwax

109

1.34

0.45

1.1

1.0

—

Injuries to the knee and lower leg

176

1.20

0.44

1.1

1.0

—

Delivery

1.45

0.44

1.0

1.1

—

Any mental disorder

145

1.21

0.44

1.1

1.0

—

Diabetes medication

156

1.22

0.44

1.1

1.0

—

Cerebrovascular diseases

0.71

0.43

1.1

1.0

—

Mycoses

191

1.23

0.43

1.1

1.0

—

Pregnancy hypertension

1.37

0.43

1.0

1.1

—

Tramadol

112

1.26

0.43

1.1

—

Delivery, wide proxy

1.48

0.43

1.0

1.1

—

Sulfonylureas

1.45

0.43

1.0

—

Other disorders of veins

1.44

0.43

1.1

1.0

—

Chronic periodontitis, including avohilmo

162

0.79

0.43

1.2

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.41

0.42

1.0

—

Concussion

1.33

0.42

1.1

1.0

—

Coxibs

1.40

0.41

1.2

1.0

—

Endometriosis of pelvic peritoneum

1.54

0.41

1.0

—

Parkinson's disease, excluding more controls

0.00

0.41

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.44

0.41

1.1

1.0

—

Diseases of tongue

0.00

0.41

0.0

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

0.41

0.0

1.0

—

Failed induction of labour

0.00

0.41

0.0

1.2

—

Other disorders of cornea

0.00

0.41

0.0

1.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.41

0.0

1.0

—

Acne

1.51

0.41

1.4

1.1

—

Parkinson's disease

0.00

0.41

0.0

1.0

—

Ocular pain

0.00

0.41

0.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.41

0.0

1.2

—

Fracture of foot, except ankle

1.36

0.41

1.0

1.1

—

Umbilical hernia

1.36

0.41

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.36

0.41

1.1

1.0

—

Metatarsalgia

0.00

0.40

0.0

1.0

—

Inguinal hernia, bilateral

0.00

0.40

0.0

1.1

—

Inguinal or femoral hernia, bilateral

0.00

0.40

0.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.34

0.40

1.0

—

Degenerative diseases of the nervous system

1.47

0.40

1.0

—

Haemorrhage from respiratory passages

1.34

0.40

1.0

—

Overexertion and strenuous or repetitive movements

0.00

0.40

0.0

1.1

—

Dentofacial anomalies [including malocclusion]

149

1.24

0.40

1.1

1.0

—

Coronary revascularization (ANGIO or CABG)

1.28

0.40

1.1

1.0

—

Type of accident

1.31

0.39

1.0

1.1

—

Endometriosis of ovary

1.43

0.39

1.0

1.1

—

Major coronary heart disease event excluding revascularizations

1.35

0.39

1.0

—

Plantar fascial fibromatosis

0.00

0.39

0.0

1.0

—

Contact with machinery

0.00

0.39

0.0

1.1

—

Disorders of synovium and tendon

116

1.28

0.38

1.1

—

Infections with a predominantly sexual mode of transmission

107

1.31

0.38

1.2

1.1

—

Vasomotor and allergic rhinitis

1.35

0.38

1.0

1.1

—

Suppurative and unspecified otitis media

1.32

0.38

1.1

—

Complications predominantly related to the puerperium

1.36

0.38

1.0

—

Persons encountering health services in circumstances related to reproduction

1.28

0.38

1.0

—

Intracranial trauma

1.28

0.38

1.1

1.0

—

Stroke, excluding SAH

0.71

0.38

1.1

1.0

—

Myopia

1.35

0.37

1.0

1.1

—

Bacterial pneumoniae

1.30

0.37

1.0

—

Atopic dermatitis, strict definition with reimbursement

1.36

0.36

1.0

1.1

—

Rotator cuff syndrome

0.74

0.35

1.1

1.0

—

Other heart diseases, wide

143

1.20

0.35

1.0

1.1

—

Propionic acid derivatives

0.67

0.34

1.2

1.0

—

Convulsions, not elsewhere classified

1.38

0.34

1.0

1.1

—

Female infertility

1.36

0.34

1.2

1.1

—

Hypertensive heart and/or renal disease

1.36

0.34

1.2

1.0

—

Migraine with aura and triptan purchases

1.36

0.34

1.2

1.0

—

Redundant prepuce, phimosis and paraphimosis

1.35

0.34

1.0

—

Statin medication

107

0.79

0.34

1.1

1.0

—

Postmenopausal bleeding

1.33

0.34

1.2

1.0

—

Ganglion

1.33

0.33

1.0

1.1

—

Primary gonarthrosis, bilateral

0.69

0.33

1.2

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.30

0.33

1.2

1.1

—

Dorsalgia

156

1.17

0.33

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

148

1.19

0.32

1.1

1.0

—

Triptan medication for migraine, single purchase ok

148

1.19

0.32

1.1

1.0

—

Other reaction to severe stress, and adjustment disorders

101

1.29

0.31

1.1

—

STROKE

0.70

0.31

1.0

—

Noninflammatory disorders of female genital tract

1.28

0.31

1.1

—

Subjective visual disturbances

1.32

0.30

1.0

1.1

—

Lumbar disc prolapse

126

0.79

0.30

1.0

1.1

—

Atopic dermatitis, strict definition

1.31

0.30

1.0

1.1

—

Neoplasms

126

1.18

0.30

1.1

—

Syncope and collapse

1.34

0.30

1.0

—

Malignant neoplasm of skin

1.34

0.30

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

108

1.26

0.29

1.1

1.0

—

Postpartum haemorrhage

1.23

0.29

1.0

1.1

—

Chronic periodontitis, complicated

106

0.75

0.29

1.1

1.0

—

Unspecified mental disorder

107

0.75

0.29

1.1

—

Other specific joint derangements/joint disorders

131

1.18

0.28

1.0

—

Disorders of sclera, cornea, iris and ciliary body

121

1.24

0.28

1.0

1.1

—

Factors influencing health status and contact with health services

1.25

0.28

1.0

—

Fracture of lower leg, including ankle

120

1.24

0.28

1.0

1.1

—

Gestational [pregnancy-induced] hypertension

1.29

0.28

1.0

1.1

—

Inflammatory diseases of female pelvic organs

111

0.79

0.27

1.2

1.1

—

Diseases of salivary glands

1.25

0.27

1.0

1.1

—

Disorders of refraction and accommodation

1.25

0.27

1.1

—

Bacterial pneumonia, not elsewhere classified

1.24

0.27

1.0

1.1

—

Other abnormal products of conception

1.28

0.27

1.1

1.0

—

Pure hypercholesterolaemia

1.22

0.27

1.1

1.0

—

Hyperplasia of prostate

1.28

0.26

1.0

1.1

—

103

1.25

0.26

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.19

0.26

1.0

1.1

—

Other functional intestinal disorders

1.27

0.26

1.2

1.1

—

Other diseases of hard tissues of teeth

0.80

0.26

1.1

1.0

—

Non-selective monoamine reuptake inhibitors

0.70

0.26

1.0

—

Coxarthrosis, primary, with hip surgery

0.67

0.26

1.0

—

Atopic dermatitis

123

1.20

0.25

1.1

—

Fracture at wrist and hand level

1.23

0.25

1.1

—

Symptoms and signs involving the urinary system

129

1.18

0.24

1.0

1.1

—

Lower back pain or/and sciatica

184

1.14

0.24

1.1

1.0

—

Coxarthrosis [arthrosis of hip](FG)

0.70

0.24

1.0

—

Schizophrenia or delusion, excluding more controls

0.73

0.24

1.2

1.0

—

Pain in throat and chest

130

1.15

0.23

1.1

—

Acute suppurative otitis media

1.28

0.23

1.1

—

Non-invasive ventilation

1.31

0.23

1.2

1.1

—

Dysphagia

1.32

0.23

1.0

—

Open wound of head

120

1.20

0.23

1.0

—

Endometriosis ASRM stages 1,2

1.28

0.23

1.0

1.1

—

Other extrapyramidal and movement disorders in other diseases

1.28

0.23

1.4

1.0

—

Spinal stenosis

0.75

0.22

1.0

—

Paroxysmal tachycardia

1.27

0.22

1.0

—

Fenamates

1.26

0.22

1.0

—

Oedema, not elsewhere classified

1.26

0.22

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

0.75

0.22

1.0

—

Primary coxarthrosis, bilateral

1.25

0.22

1.0

—

Open wound of wrist and hand

113

1.21

0.22

1.0

—

Pain in joint

1.18

0.22

1.1

1.0

—

Fracture of skull and facial bones

1.22

0.22

1.4

1.0

—

Unspecified dementia

0.00

0.21

0.0

1.0

—

Crossbite

0.00

0.21

0.0

1.1

—

Congenital malformations of cardiac septa

0.00

0.21

0.0

1.1

—

Septal defects

0.00

0.21

0.0

1.1

—

Cervicalgia

1.19

0.21

1.2

1.0

—

Oligomenorrhoea

0.00

0.21

0.0

1.1

—

Dissociative [conversion] disorders

0.00

0.21

0.0

1.0

—

Open bite

0.00

0.21

0.0

1.1

—

Convergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Other and unspecified injuries of head

0.00

0.21

0.0

1.0

—

Alcohol withdrawal state with delirium

0.00

0.21

0.0

1.1

—

Chronic suppurative otitis media

0.00

0.21

0.0

1.1

—

Pedestrian injured in transport accident

0.00

0.21

0.0

1.0

—

Nontoxic single thyroid nodule

0.00

0.21

0.0

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

0.21

0.0

1.0

—

Spirochaetal infections, other/unspecified

0.00

0.21

0.0

1.0

—

Haemangioma, any site

0.00

0.21

0.0

1.0

—

Vestibular neuronitis

0.00

0.21

0.0

1.0

—

Memory loss

0.00

0.21

0.0

1.0

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

0.21

0.0

1.0

—

Speech disturbances, not elsewhere classified

0.00

0.21

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.0

—

Use of rivastigmine

0.00

0.21

0.0

1.0

—

Other neurological diseases

123

0.83

0.21

1.1

1.0

—

Hypertensive diseases (excluding secondary)

1.21

0.21

1.1

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

140

1.14

0.21

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

0.76

0.21

1.1

1.0

—

Bulimia nervosa (incl. atypical)

0.00

0.21

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

0.21

0.0

1.0

—

Other obstetric trauma

0.00

0.21

0.0

1.2

—

Desensitization to allergens

0.00

0.21

0.0

1.1

—

Chronic suppurative otitis media, including avohilmo

0.00

0.21

0.0

1.1

—

Other peripheral vertigo

0.00

0.21

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

1.0

—

Benign neoplasm: Caecum

0.00

0.21

0.0

1.0

—

Bronchitis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.21

0.0

1.0

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

101

1.15

0.21

1.1

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.16

0.21

1.2

1.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.21

0.0

1.0

—

Unspecified urinary incontinence

0.00

0.21

0.0

1.0

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Benign neoplasm of eye and adnexa

0.00

0.21

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

0.21

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.21

0.0

1.0

—

Spondylopathies

114

1.15

0.20

1.0

1.1

—

Diseases of inner ear

1.22

0.20

1.0

1.1

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.20

0.0

1.0

—

Angina pectoris

1.24

0.20

1.0

—

Asthma-related infections

142

1.17

0.20

1.0

1.1

—

Asthma, hospital admission 2, infections

142

1.17

0.20

1.0

1.1

—

Varicose veins

0.80

0.20

1.1

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.20

0.0

1.1

—

Endometriosis of rectovaginal septum and vagina

0.00

0.20

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

0.20

0.0

1.1

—

Lichen planus

0.00

0.20

0.0

1.0

—

Bipolar affective disorders

1.25

0.20

1.5

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

171

0.88

0.20

1.0

1.1

—

Appendectomy

157

1.16

0.20

1.0

1.1

—

Combinations of oral blood glucose lowering drugs

1.20

0.19

1.0

—

Generalized anxiety disorder

1.18

0.19

1.0

—

Gastro-oesophageal reflux disease

126

1.16

0.19

1.0

1.1

—

Pregnancy, childbirth and the puerperium

1.22

0.19

1.0

1.1

—

Basal cell carcinoma

1.21

0.18

1.0

1.1

—

Dysplasia of cervi uteri

1.21

0.18

1.1

1.0

—

Myocardial infarction, without ST-elevation

1.20

0.18

1.0

—

Fall on same level involving ice and snow

128

1.17

0.18

1.1

—

Spondylosis

1.19

0.18

1.0

—

Other diseases of anus and rectum

1.16

0.17

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.20

0.17

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.15

0.17

1.3

1.1

—

Diaphragmatic hernia

1.15

0.17

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.16

0.17

1.1

1.0

—

Presence of cardiac and vascular implants and grafts

1.13

0.17

1.0

—

Ischaemic heart disease, wide definition

1.17

0.17

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.11

0.17

1.1

1.0

—

Soft tissue disorders

159

1.10

0.17

1.1

—

Deviated nasal septum

0.73

0.17

1.2

1.0

—

Extrapyramidal and movement disorders

0.71

0.16

1.4

1.0

—

Disorders of vestibular function (Vertigo)

1.21

0.16

1.0

—

Disease of hard tissues of teeth, NOS

1.15

0.16

1.1

1.0

—

Keratitis

1.14

0.16

1.0

1.1

—

Fracture of shoulder and upper arm

1.14

0.16

1.0

—

Asthma/COPD (KELA code 203)

169

0.89

0.16

1.0

1.1

—

Myocardial infarction, strict

1.12

0.16

1.0

—

Abnormalities of heart beat

1.12

0.16

1.1

—

Allergic conjunctivitis

137

0.85

0.16

1.2

1.1

—

Cholecystectomy

120

1.15

0.15

1.1

—

Menorrhagia

1.13

0.15

1.1

1.0

—

Schizophrenia or delusion

0.79

0.15

1.2

1.1

—

Schizophrenia, schizotypal and delusional disorders

0.79

0.15

1.2

1.1

—

Irregular menses

1.16

0.15

1.1

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

0.78

0.15

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

101

0.88

0.15

1.2

1.0

—

Cough

1.12

0.15

1.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

117

1.12

0.15

1.1

—

Arthrosis

0.86

0.15

1.1

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.11

0.15

1.1

—

Striking against or struck by other objects

1.08

0.14

1.0

1.1

—

Ovarian cyst

0.82

0.14

1.0

1.1

—

Dental caries, including avohilmo

1.13

0.14

1.1

1.0

—

Selective serotonin reuptake inhibitors

148

1.09

0.14

1.1

1.0

—

Nerve, nerve root and plexus disorders

168

1.09

0.14

1.0

1.1

—

Major coronary heart disease event

1.13

0.14

1.1

1.0

—

Allergic rhinitis

1.19

0.14

1.0

1.1

—

Ischemic heart diseases

1.13

0.13

1.1

1.0

—

Injuries to the hip and thigh

1.17

0.13

1.2

1.0

—

Glaucoma

1.17

0.12

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

133

0.88

0.11

1.2

1.1

—

Temporomandibular joint disorders, including avohilmo

114

0.86

0.11

1.0

1.1

—

Dizziness and giddiness

141

0.90

0.11

1.0

1.1

—

Other headache syndromes

1.16

0.10

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

127

1.09

0.10

1.0

—

Other dorsopathies, not elsewhere classified

156

1.07

0.10

1.1

—

Periodontitis

160

0.92

0.10

1.2

1.0

—

Migraine

101

1.12

0.10

1.1

—

Disorders of conjunctiva

175

0.92

0.10

1.2

1.0

—

Adverse effects, not elsewhere classified

1.09

0.09

1.0

1.1

—

Fracture of rib(s), sternum and thoracic spine

1.09

0.09

1.0

—

Supervision of normal pregnancy

1.06

0.09

1.0

1.1

—

Endometriosis ASRM stages 3,4

1.06

0.09

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

101

0.91

0.09

1.0

—

Other and unspecified nonorganic psychotic disorders

1.04

0.09

1.2

1.1

—

malignant neoplasm of male genital organs

1.14

0.09

1.0

1.1

—

Coronary atherosclerosis

1.13

0.09

1.0

—

HSIL lesion of the cervix uteri

1.11

0.09

1.2

1.1

—

Retinal detachments and breaks

1.09

0.08

1.0

—

Calculus of kidney and ureter

1.07

0.08

1.0

1.1

—

Epilepsy

1.07

0.08

1.0

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

1.05

0.08

1.2

1.1

—

Migraine without aura

1.05

0.08

1.2

1.1

—

Basal cell carcinoma, including avohilmo

1.03

0.08

1.0

1.1

—

Erosion of teeth , including avohilmo

0.83

0.08

1.0

1.1

—

Degeneration of macula and posterior pole

1.07

0.08

1.0

—

Single spontaneous delivery

1.06

0.07

1.0

1.1

—

Examination and observation for other reasons

101

0.92

0.07

1.1

1.0

—

Myocardial infarction

1.04

0.07

1.0

—

Spontaneous abortion

1.11

0.07

1.1

—

Acetic acid derivatives and related substances

1.06

0.07

1.1

1.0

—

Senile cataract

1.12

0.07

1.0

—

Other arrhythmias

100

0.91

0.07

1.0

1.1

—

Other arthrosis

0.84

0.07

1.3

1.0

—

Periapical abscess

0.84

0.06

1.0

1.1

—

Embedded and impacted teeth

0.86

0.06

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

110

0.90

0.05

1.1

—

Sensorineural hearing loss

1.08

0.05

1.1

1.0

—

Gonarthrosis

0.91

0.05

1.0

—

Injuries to the ankle and foot

170

0.94

0.05

1.1

1.0

—

Asthma, hospital admissions , main diagnosis only

184

1.05

0.04

1.0

1.1

—

Persons encountering health services for examination and investigation

101

0.94

0.04

1.1

1.0

—

Any death

1.09

0.04

1.0

—

Medical abortion

0.93

0.04

1.1

1.0

—

Conjunctivitis

167

0.95

0.03

1.2

1.0

—

Dental operations

1.07

0.03

1.1

1.0

—

Sciatica+with lumbago

112

1.07

0.03

1.2

1.1

—

Falls/tendency to fall

160

1.03

0.03

1.2

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.07

0.02

1.2

1.1

—

Pregnancy with abortive outcome

0.95

0.02

1.2

1.0

—

Hernia

153

0.96

0.02

1.0

—

Conductive and sensorineural hearing loss

103

1.05

0.01

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

110

0.94

0.01

1.0

—

Diseases of the eye and adnexa

124

0.97

0.01

1.0

1.1

—

Cardiac arrhythmias

1.05

0.01

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

163

0.96

0.01

1.1

1.0

—

Disorders of breast

1.06

0.01

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

117

1.04

0.01

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

111

1.04

0.01

1.1

—

Dorsopathies

156

0.98

0.01

1.1

—

Biguanides

138

0.97

0.00

1.1

1.0

—

Excessive attrition of teeth

146

0.96

0.00

1.1

—

Gingivitis and periodontal diseases

140

0.99

0.00

1.1

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.02

0.00

1.0

—

Fall on same level

181

1.00

0.00

1.1

1.0

—

Injuries to the shoulder and upper arm

169

1.00

0.00

1.0

1.1

—

Antihypertensive medication - note that there are other indications

107

0.99

0.00

1.2

1.0

—

Gonarthrosis [arthrosis of knee](FG)

0.98

0.00

1.0

—

Hard cardiovascular diseases

1.03

0.00

1.1

1.0

—

Fracture of forearm

102

0.99

0.00

1.1

1.0

—

Caries of enamel

173

1.00

0.00

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

146

0.99

0.00

1.0

—

Diverticular disease of intestine

0.98

0.00

1.0

—

Contraceptive management

1.05

0.00

1.1

—

Other (not insulin) diabetes medications

135

1.01

0.00

1.2

1.0

—

Polycystic ovarian syndrome, consortium definition

104

1.03

0.00

1.2

1.0

—

Sequelae of injuries of head

0.00

0.0

1.0

—

Noise effects on inner ear

0.00

0.0

1.0

—

Dystonia

0.00

0.0

1.0

—

Impacted cerumen

0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland

0.00

0.0

1.0

—

Injury of nerves at wrist and hand level

0.00

0.0

1.0

—

Other disorders of eyelid

0.94

0.00

1.2

1.0

—

Malignant neoplasm of digestive organs

0.92

0.00

1.2

1.0

—

Wide developmental disorders

0.00

0.0

1.1

—

Bicuspidal aortic valve syndrome

0.00

0.0

1.0

—

Bullous disorders

0.00

0.0

1.0

—

Corns and callosities

0.00

0.0

1.0

—

Other congenital malformations of face and neck

0.00

0.0

1.0

—

L02BX Other hormone antagonists and related agents

0.00

0.0

1.0

—

Barrett oesophagus

0.00

0.0

1.0

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.0

1.0

—

Irritable bowel syndrome

0.95

0.00

1.0

1.1

—

Congenital malformations of uterus and cervix

0.00

0.0

1.0

—

Other noninfective disorders of lymphatic vessels and lymph nodes

0.00

0.0

1.0

—

LeFortI or BSSO operation

0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

0.0

1.0

—

Use of biperiden

0.00

0.0

1.0

—

Attention to artificial openings

0.00

-0.00

0.0

1.0

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.0

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.0

—

Schizotypal disorder

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

1.0

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

-0.00

0.0

1.0

—

Endometriosis

0.90

-0.00

1.0

1.1

—

Autism spe

0.00

-0.00

0.0

1.2

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.0

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in transport accident

0.93

-0.00

1.0

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.88

-0.00

1.1

—

Urolithiasis

1.00

-0.00

1.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

Allergic asthma (mode)

0.98

-0.00

1.0

1.1

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.1

—

Postpartum hemorraghe, all women as controls

0.97

-0.00

1.0

1.1

—

Keratoconus

0.00

-0.00

0.0

1.0

—

Hyperhidrosis

0.00

-0.00

0.0

1.0

—

Polyp of the female genital tract

0.93

-0.00

1.0

1.1

—

Autism

0.00

-0.00

0.0

1.1

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

-0.00

0.0

1.0

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.0

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

1.0

—

Other secondary gonarthrosis

0.00

-0.00

0.0

1.0

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.0

—

Dementia in other diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Atrial septal defect

0.00

-0.00

0.0

1.0

—

Faecal incontinence

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, including Hilmo

0.87

-0.00

1.0

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

1.0

—

Bacterial meningitis

0.00

-0.00

0.0

1.0

—

Pleural plaque with presence of asbestos

0.00

-0.00

0.0

1.0

—

Small fibre neuropathy

0.00

-0.00

0.0

1.0

—

Endometriosis of intestine

0.00

-0.00

0.0

1.0

—

Allergic asthma (mode), excluding more controls

0.98

-0.00

1.0

1.1

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.0

—

Other and unspecified corneal deformities and disorders

0.00

-0.00

0.0

1.0

—

Effects of foreign body entering through natural orifice

0.94

-0.00

1.0

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.0

—

Other/unspecified reactive arthropathies

0.00

-0.00

0.0

1.0

—

Impacted teeth

0.96

-0.00

1.0

1.1

—

Erectile dysfunction

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.0

—

Ulcer of oesophagus

0.00

-0.00

0.0

1.0

—

Papillary adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

-0.00

0.0

1.0

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

1.0

—

Atypical facial pain

0.00

-0.00

0.0

1.0

—

Kela-code for severe mental illness

0.91

-0.00

1.1

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.0

—

Injuries to the thorax

0.93

-0.00

1.0

1.1

—

Prepatellar bursitis

0.00

-0.00

0.0

1.0

—

Other specified/unspecified bacterial intestinal infections

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Special screening examination for neoplasms

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases

0.00

-0.00

0.0

1.0

—

Atrial septal defect, secundum type

0.00

-0.00

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the cervix uteri

0.98

-0.00

1.1

—

Embolic stroke

0.00

-0.00

0.0

1.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

therapeutic use

0.00

-0.00

0.0

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.02

-0.00

1.2

1.0

—

Chondrocostal junction syndrome [Tietze]

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

-0.00

0.0

1.0

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Inguinal of femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Postpartum hemorraghe, parous women as controls

0.88

-0.00

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Conjunctivitis (acute, non atopic)

0.98

-0.00

1.1

—

Other infective otitis externa

0.00

-0.00

0.0

1.0

—

Other diseases of lip and oral mucosa

0.92

-0.00

1.1

—

Polypectomy (DHB20)

0.00

-0.00

0.0

1.0

—

Cholesteatoma of middle ear

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at ankle and foot level

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.0

—

Vascular disorders of the intestines

0.00

-0.00

0.0

1.0

—

Femoral hernia

0.00

-0.00

0.0

1.0

—

Subacute thyroiditis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast

0.88

-0.00

1.0

—

Other specified/unspecified soft tissue disorders

0.00

-0.00

0.0

1.0

—

Dermatitis due to ingested food

0.00

-0.00

0.0

1.1

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Mixed hyperlipidaemia

0.00

-0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

Femoral hernia, unilateral

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Convalescence

0.00

-0.00

0.0

1.0

—

Occupational exposure to risk-factors

0.00

-0.00

0.0

1.0

—

Bicipital tendinitis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative

0.91

-0.00

1.0

—

Neuralgia and neuritis, unspecified

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Early onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Left ventricular outflow tract obstruction, narrow definition

0.00

-0.00

0.0

1.0

—

Other and unspecified coagulation defects

0.00

-0.00

0.0

1.0

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

1.0

—

Use of selegiline

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.87

-0.00

1.0

—

Unspecified misadventure during surgical and medical care

0.00

-0.00

0.0

1.0

—

Pleural plaque

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of other and unspecified digestive organs

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other and unspecified parts of mouth

0.00

-0.00

0.0

1.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Soft tissue disorders related to use, overuse and pressure

0.94

-0.00

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

-0.00

0.0

1.0

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.0

—

Inguinal hernia, unilateral

0.00

-0.00

0.0

1.0

—

Other aneurysm

0.00

-0.00

0.0

1.0

—

Right hemicolectomy

0.00

-0.00

0.0

1.0

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.0

—

Myeloproliferative diseases (CML excluded)

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.0

—

Tongue abnormality

0.00

-0.00

0.0

1.0

—

Glucosamine medication

0.98

-0.00

1.2

1.0

—

Persistent delusional disorders

0.00

-0.00

0.0

1.0

—

Molar incisor enamel hypoplasia

0.00

-0.00

0.0

1.2

—

Other benign neoplasms of uterus

0.00

-0.00

0.0

1.0

—

Muscle strain

0.00

-0.00

0.0

1.0

—

Unspecified jaundice

0.00

-0.00

0.0

1.0

—

Hypertrophic scar

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Skin of trunk

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.1

—

Intestinal malabsorption

0.00

-0.00

0.0

1.0

—

Undefined dementia

0.00

-0.00

0.0

1.0

—

L01XX Other antineoplastic agents

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

HIV 1+2 Ab [Presence] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS